Dr. Fatih Mehmet Ucar

About Dr. Fatih Mehmet Ucar

Dr. Fatih Mehmet Uçar's medical journey started in 2002 when he enrolled in Kocaeli Anatolian High School and continued in 2008 when he enrolled in Selçuk University Meram Faculty of Medicine.
He started specialized training at Türkiye Higher Specialization Training and Research Hospital in 2013 after receiving his medical degree, which allowed him to expand his knowledge in the field of his choice.
To broaden his skills, Dr. Fatih Mehmet Uçar sought additional training at the University of Lübeck's Arrhythmia Clinic in Germany, where he learned much about treating cardiac arrhythmias.
After returning to Turkey, he worked in various medical facilities, such as Türkiye Higher Specialization Hospital, Denizli State Hospital, and Edirne State Hospital, to improve his skills and help the local population.
Dr. Fatih Mehmet Uçar had the honor of receiving training at the esteemed Cleveland Clinic in the United States, which allowed him to further strengthen medical knowledge and skills in the pursuit of excellence and global collaboration.
He has remained committed to improving healthcare, providing kind treatment for patients, and making a positive impact on the international medical community throughout his journey.

Conditions treated by Dr. Fatih Mehmet Uçar

Radiofrequency ablation
Aneurysm coiling
Intracranial Arterial Angioplasty and Stenting
Covered Stent Placement
Carotid Angioplasty and Stenting
Transluminal Arterial Angioplasty (PTA) and Stenting
Endovenous radiofrequency ablation (EVRF)
Plastic surgery for cardiac valve
Paediatric Check-Up
CT (computer tomography)
Heart сheck up
Echocardiography
Body composition analysis

Area of Interest

Pacemaker
Rhythm Disorders
Electrophysiology
Coronary Angiography

Qualification

2002 - Kocaeli Anatolian High School
2008 - Selçuk University Meram Faculty of Medicine
2013 - Türkiye Higher Specialization Training and Research Hospital \ Specialization Training
Arrhythmia Clinic, University of Lübeck, Germany
Türkiye Higher Specialization Hospital
Denizli State Hospital
Edirne State Hospital
Cleveland Clinic, United States

Global Team of Board Certified Surgeons and Medical Specialists
Written Second Opinion report delivered within 5 days
Option to avail the Video Consultation with the Lead Doctor of the board

Access Our most trusted Medical Second Opinion

Telemedicine Doctors

MEMBERSHIPS (3)

Turkish Cardiology Association, Member
European Society of Cardiology
European Arrhythmia Association (EHRA)

RESEARCH PAPERS AND PUBLICATIONS (23)

Contemporary Management of Severe Symptomatic Aortic Stenosis. Eugène M, Duchnowski P, Prendergast B, Wendler O, Laroche C, Monin JL, Jobic Y, Popescu BA, Bax JJ, Vahanian A, Iung B; EORP VHD II Registry Investigators Group. J (Ucar FM) Am Coll Cardiol. 2021 Nov 30;78(22):2131-2143. doi: 10.1016/j.jacc.2021.09.864.PMID:34823655
ICD-detected patient activity is associated with arrhythmic events in heart failure patients. Ucar FM, Yilmaztepe MA.Niger J Clin Pract. 2020 Nov;23(11):1615-1620. doi: 10.4103/njcp.njcp_24_20.PMID:33221790
Mobitz type II, 2:1 atrioventricular block mimicking a convulsive seizure. Kaya Ç, Zeybey U, Akpınar M, Taylan G, Uçar FM . Anatol J Cardiol. 2019 Sep;22(4):202-203. doi: 10.14744/AnatolJCardiol.2019.88646.PMID:31584444.
Evaluation of Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc ratio in patients with acute myocarditis. Ucar FM, Ozturk C, Yılmaztepe MA.BMC Cardiovasc Disord. 2019 Oct 22;19(1):232. doi: 10.1186/s12872-019-1207-z.PMID:31640548
Unexpected pacemaker complication: all implanted leads on the left heart. Kaya Ç, Çakır B, Uçar FM, Yılmaztepe MA.Turk Kardiyol Dern Ars. 2019 Jun;47(4):329. doi: 10.5543/tkda.2019.47596.PMID:31219444Free article.English.
Pacemaker follow-up after device replacement. Ucar FM.Herz. 2019 Feb;44(1):82. doi: 10.1007/s00059-017-4658-y. Epub 2017 Dec 12.PMID:29234841English.
The implantable cardiac monitor and pocket infection. Ucar FM. Each Z. 2019 Jun;44(4):363. doi: 10.1007/s00059-017-4651-5. Epub 2017 Dec 5.PMID:29209840.
The prevalence of cardiovascular diseases, risk factors, and cardiovascular drug therapy in very elderly Turkish patients admitted to cardiology clinics: A subgroup analysis of the ELDER-TURK study. Gök G, Sinan ÜY, Özyüncü N, Zoghi M; ELDER-TÜRK Investigators (Ucar FM).Turk Kardiyol Dern Ars. 2018 Jun;46(4):283-295. Doi: 10.5543/tkda.2018.49579. PMID:29853696
Yalta K, Ucar F, Yilmaztepe M, Zorkun C.Int J Cardiol. 2017 Nov 1;246:61. doi: 10.1016/j.ijcard.2017.05.110.PMID:28867021
Neutrophil to Lymphocyte ratio predicts appropriate therapy in idiopathic dilated cardiomyopathy patients with primary prevention implantable cardioverter defibrillator. Uçar FM, Açar B.Saudi Med J. 2017 Feb;38(2):143-148. doi: 10.15537/smj.2017.2.15929.PMID:28133686.
New oral anticoagulants-TURKey (NOAC-TURK): Multicenter cross-sectional study. Altay S, Yıldırımtürk Ö, Çakmak HA, Aşkın L, Sinan ÜY, Beşli F, Gedikli Ö, Özden Tok Ö; NOAC-TURK Study Collaborators.(Ucar FM) Anatol J Cardiol. 2017 May;17(5):353-361. doi: 10.14744/AnatolJCardiol.2016.7472. Epub 2017 Jan 17.PMID:28100898
Non-Sustained Ventricular Tachycardia Episodes Predict Future Hospitalization in ICD Recipients with Heart Failure. Uçar FM, Yilmaztepe MA, Taylan G, Aktoz M.Arq Bras Cardiol. 2017 Oct;109(4):284-289. doi: 10.5935/abc.20170141.PMID:28977051
Association between RDW and stent thrombosis in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Tunçez A, Çetin MS, Çetin EHÖ, Yilmaz S, Korkmaz A, Uçar FM . Medicine (Baltimore). 2017 Feb;96(5):e5986. doi: 10.1097/MD.0000000000005986.PMID:28151892
Gamma-glutamyl transferase predicts recurrences of atrial fibrillation after catheter ablation. Uçar FM, Gucuk İpek E, Acar B, Gul M, Tunçez A, Özeke Ö, Geyik B, Topaloglu S, Aras D.Acta Cardiol. 2016 Apr;71(2):205-10. doi: 10.2143/AC.71.2.3141851.PMID:27090043
Massive pulmonary embolism and a cardiac mass: Thrombus or metastasis? Gül M, Babat N, Uçar FM, Kuyumcu MS, Özeke Ö.Turk Kardiyol Dern Ars. 2016 Oct;44(7):597-599. doi: 10.5543/tkda.2016.77772.PMID:27774970
A potential marker of bare metal stent restenosis: monocyte count - to HDL cholesterol ratio. Ucar FM.BMC Cardiovasc Disord. 2016 Oct 3;16(1):186. doi: 10.1186/s12872-016-0367-3.PMID:27716070
Long-term outcome in patients with prosthetic valve endocarditis: results from a single center in Turkey. Güray Y, Güçlük İpek E, Acar B, Kuyumcu MS, Uçar F, Kafes H, Asarcıklı L, Çabuk G, Demirkan B, Güray Ü.Turk Kardiyol Dern Ars. 2016 Mar;44(2):105-13. doi: 10.5543/tkda.2015.21504.PMID:27111308
Massive Myocardial Staining and Thebesian Venous Opacification during Complicated Coronary Angiography. Ucar FM, Ozeke O, Duman I, Canpolat U, Kisacik HL.Int J Angiol. 2016 Dec;25(5):e19-e20. doi: 10.1055/s-0034-1396930. Epub 2015 Jan 14.PMID:28058031
Programming implantable cardioverter-defibrillator therapy zones to high ranges to prevent delivery of inappropriate device therapies in patients with primary prevention: results from the RISSY-ICD (Reduction of Inappropriate ShockS by InCreaseD zones) trial. Cay S, Canpolat U, Ucar F, Ozeke O, Ozcan F, Topaloglu S, Aras D.Am J Cardiol. 2015 May 1;115(9):1235-43. doi: 10.1016/j.amjcard.2015.01.558. Epub 2015 Feb 12.PMID:25765588
Case images: apical pouches with hypertrophic cardiomyopathy. Uçar FM, Ozeke O, Topaloğlu S, Gölbaşı Z.Turk Kardiyol Dern Ars. 2014 Sep;42(6):589. doi: 10.5543/tkda.2014.28828.PMID:25362957Free article.
Airbag inflation-related left main coronary artery dissection, localized aortic dissection, and aortic valve dehiscence in a patient with a previous coronary artery. Uçar FM, Sen F, Karamanlioğli M, Çağli K.Int J Cardiol. 2014 Apr 15;173(1):118-9. doi: 10.1016/j.ijcard.2014.01.010. Epub 2014 Feb 1.PMID:24612611
A rare coronary artery anomaly: posterior descending artery arising from septal perforator artery. Uçar FM, Gül M, Okten RS, Topaloğlu S, Güçlük E.Turk Kardiyol Dern Ars. 2013 Oct;41(7):668. doi: 10.5543/tkda.2013.48840.PMID:24165004
Coronary artery-left ventricular micro-fistulas associated with apical hypertrophic cardiomyopathy. Yılmaz S, Uçar FM, Gölbaşı Z, Tüfekçioğlu O. Anadolu Kardiyol Derg. 2012 Aug 31;12(6):E28. doi: 10.5152/akd.2012.175.PMID:22728741

Share Your Experience about Dr. Fatih Mehmet Ucar

Write Your Review

PROCEDURES

Angiography (Including Non-Ionic Contrast)
Balloon mitral valvotomy
Cardiac catheterization
CRT - D
CRT - P
Glenn procedure
Impella
Intra-aortic balloon pump (IABP)
Pulmonary Valve Replacement

FREQUENTLY ASKED QUESTIONS

Q: Is Doctor Fatih Mehmet Ucar doing teleconsultation on the MediGence platform?

A. Dr. Fatih Mehmet Ucar is available to teleconsultate on the MediGence platform.

Q: How long is the consultation?

A. The consultation can last up to 15 to 30 minutes. It may go beyond the estimated time which is dependent on the patient’s queries and the medical suggestions of the doctor.

Q: How soon can the consultation be organized?

A. We have Medical specialists and board-certified doctors on our panel of doctors. The consultation will be organized within 24 to 48 hours or based on the availability of the doctor and the patient.

Q: Is follow-up consultation included in the consultation price?

A. No, the follow-up consultation fee is not included in the consultation price. The patient will be required to re-book the consultation.

Q: How do I share my medical record with the doctor for review?

A. The option to share your medical records is available between the steps of the form provided to you on the website.

Q: Can I book my procedure with the doctor post-consultation?

A. Yes. If you are satisfied with the consultation, then you can go ahead with treatment packages for your diagnosis with the help of our case managers.

Q: Is it possible to get the estimate for the procedure?

A. Yes. The cost estimate will be provided to you by our case manager including the doctor’s opinion, the cost estimate, and the crucial information about traveling to your medical destination.

Welcome To MediGence

Your Notifications